CXCL13/BCA-1/BLC Human Monoclonal Antibody
Anti-Human CXCL13/BCA-1/BLC (BVLZ9) is a research-grade recombinant antibody targeting SCYB13. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
SCYB13, BLC, CXCL13, B cell-attracting chemokine 1, B lymphocyte chemoattractant, Small-inducible cytokine B13, CXC chemokine BLC, Angie, C-X-C motif chemokine 13, BCA-1, BCA1
UniProt
O43927
Reactivity
Human
Clonality
Monoclonal
Clone
BVLZ9
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-47371PEP 0.1 mL
MMS19 like protein Recombinant Protein Antigen
Sign In for Pricing
View Details 
042286-Biotin 200 µL
SRA1, CT (SRA1, Steroid receptor RNA activator 1, Steroid receptor RNA activator protein) (Biotin) discontinued
Sign In for Pricing
View Details